(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 15.79% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.4%.
Twist Bioscience's revenue in 2026 is $376,572,000.On average, 13 Wall Street analysts forecast TWST's revenue for 2026 to be $26,888,009,993, with the lowest TWST revenue forecast at $25,702,961,249, and the highest TWST revenue forecast at $27,826,632,192. On average, 13 Wall Street analysts forecast TWST's revenue for 2027 to be $30,937,843,755, with the lowest TWST revenue forecast at $29,109,517,777, and the highest TWST revenue forecast at $32,359,535,359.
In 2028, TWST is forecast to generate $35,962,377,051 in revenue, with the lowest revenue forecast at $33,078,636,145 and the highest revenue forecast at $37,624,380,398.